Missouri SB1569 mandates insurance coverage for treatments of perimenopause, menopause, and postmenopause.
Missouri SB1569 introduces provisions requiring health carriers and health benefit plans to cover treatments for perimenopause, menopause, and postmenopause. This includes hormone therapy, SSRIs, SNRIs, vaginal estrogen, osteoporosis medications, neurokinin B antagonists, topical hormone therapy, and bioidentical hormones. The bill mandates that this coverage be provided without greater deductibles or copayments than other similar health care services. The provisions do not apply to supplemental insurance policies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.